Buspirone Hydrochloride Tablet
Product Images NDC 59651-393

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 59651-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Patient Instruction Sheet (Buspirone Fig1)

This appears to be a description of different dosages and their corresponding tablets used for a certain medication prescribed by a doctor. It lists the dosage amounts in milligrams and the different tablet sizes including their front and back sides. It also shows information on how to divide the tablets for smaller dosages.*

FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablets Bottle))

Each tablet contains 30 mg of Buspirone hydrochloride USP. This medication is distributed by Aurobindo Pharma USA, Inc. The usual dosage should be consulted through the package insert. The tablets are made in India and should be stored within a controlled room temperature below 30°C (86°F). It is important to protect the tablets from temperatures greater than 30°C (86°F) and dispense them in a tight, light-resistant container (USP). The code AP/DRUGS/04/2016 and the NDC number 59651-393-30 are provided. This medication is only available with a prescription.*

FDA Label Image

Package Label-principal Display Panel (30 mg Blister Carton (10 x 10 Unit-Dose))

Buspirone Hydrochloride Tablets, USP with a strength of 30mg are manufactured by Aurobindo Pharma. The package contains 100 tablets in the form of 10 blister cards each containing 10 tablets. The tablets are not childproof. The usual dosage information can be found in the package insert. These tablets should be stored at a temperature range of 20°C to 25°C or 68°F to 77°F and should be protected from temperatures above 30°C or 86°F. The package is marked with the product code AP/DRUGS/04/2016.*

FDA Label Image

Figure (Buspirone Fig2)

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Each tablet contains 5mg of Buspirone hydrochloride USP and is distributed by Aurobindo Pharma USA, Inc. The usual dosage can be found in the package insert. The tablets are made in India and should be stored at 20-25°C. Dispensing should be done in a tight, light-resistant container (USP). The text includes a code and a warning not to print in the designated area.*

FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-Dose))

BusPIRone Hydrochloride Tablets, USP is an FDA approved prescription medicine used to treat anxiety. Each unit-dose package contains 100 tablets of 5 mg Buspirone hydrochloride USP. The recommended dosage should be followed as per the package insert. It is advised to store the medicine at 20° to 25°C (68° to 77°F) and protect from temperatures greater than 30°C (86°F). This medicine is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablets Bottle))

Each tablet contains 7.5 mg of Buspirone hydrochloride USP. This drug is distributed by Aurohindo Pharma USA, Inc, and comes with dosage instructions in the package insert. It is made in India and must be stored under controlled room temperature. The tablets come in a container with a tight, light-resistant seal. The product's code is AP/DRUGS/04/2016, and it is only available with a prescription.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Each tablet contains 10mg of Buspirone hydrochloride USP, distributed by Aurobindo Pharma USA, Inc. The usual dosage is listed in the package insert and the tablets should be stored between 20-25°C (68-77°F). They should be protected from temperatures exceeding 30°C (86°F) and dispensed in a tight, light-resistant container. The tablets are Rx only and made in India. The code for the product is AP/DRUGS/04/2016. The rest of the text is a printing code and not relevant.*

FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (10 x 10 Unit-Dose))

This is a prescription medication with the NDC code 59651-391-78. It contains Buspirone hydrochloride USP 10 mg and is a tablet. The usual dosage is mentioned on the package insert. The medication needs to be stored at room temperature and protected from temperatures greater than 30°C (86°F). The package contains 100 unit dose tablets, with 10 tablets in each strip. This medication is manufactured by Aurobindo Pharma Limited in East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

This is a prescription medicine with the NDC number 59651-392-30. The medicine is BusPIRone Hydrochloride, which comes in the form of tablets. Each tablet contains 15 mg of Buspirone Hydrochloride USP. The usual dosage is indicated in the package insert. It should be stored between 20° to 25°C and protected from temperatures above 30°C. The medicine is distributed by Aurohindo Pharma USA, Inc. and was made in India in April 2016.*

FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (10 x 10 Unit-Dose))

This is a description of Buspirone Hydrochloride tablets, USP manufactured by Aurobindo Pharma USA, Inc. The tablets come in a unit-dose package containing 100 pills (10 blister cards with 10 pills in each). Each pill has 15mg of Buspirone hydrochloride USP. The package is not child-resistant and should be stored at 20° to 25°C (68° to 77°F), protected from temperatures greater than 30°C (86°F). The dosage information is available in the package insert. The code for the tablets is AP/DRUGS/04/2016. There is also some unreadable text.*

FDA Label Image

Chemical Structure (Buspirone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.